- Home
- QTRX vs DCTH Comparison
QTRX vs DCTH Comparison
Compare QTRX & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- DCTH
- Stock Information
- Founded
- QTRX 2007
- DCTH 1988
- Country
- QTRX United States
- DCTH United States
- Employees
- QTRX N/A
- DCTH N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- DCTH Medical/Dental Instruments
- Sector
- QTRX Industrials
- DCTH Health Care
- Exchange
- QTRX Nasdaq
- DCTH Nasdaq
- Market Cap
- QTRX 439.1M
- DCTH 518.0M
- IPO Year
- QTRX 2017
- DCTH N/A
- Fundamental
- Price
- QTRX $9.65
- DCTH $15.26
- Analyst Decision
- QTRX Strong Buy
- DCTH Strong Buy
- Analyst Count
- QTRX 4
- DCTH 4
- Target Price
- QTRX $23.25
- DCTH $22.25
- AVG Volume (30 Days)
- QTRX 769.1K
- DCTH 407.3K
- Earning Date
- QTRX 03-17-2025
- DCTH 11-08-2024
- Dividend Yield
- QTRX N/A
- DCTH N/A
- EPS Growth
- QTRX N/A
- DCTH N/A
- EPS
- QTRX N/A
- DCTH N/A
- Revenue
- QTRX $133,809,000.00
- DCTH $22,644,000.00
- Revenue This Year
- QTRX $13.79
- DCTH $1,605.13
- Revenue Next Year
- QTRX $15.34
- DCTH $111.67
- P/E Ratio
- QTRX N/A
- DCTH N/A
- Revenue Growth
- QTRX 14.72
- DCTH 945.91
- 52 Week Low
- QTRX $8.21
- DCTH $3.70
- 52 Week High
- QTRX $29.70
- DCTH $15.05
- Technical
- Relative Strength Index (RSI)
- QTRX 43.51
- DCTH 74.95
- Support Level
- QTRX $8.21
- DCTH $12.14
- Resistance Level
- QTRX $10.39
- DCTH $12.98
- Average True Range (ATR)
- QTRX 0.90
- DCTH 0.81
- MACD
- QTRX -0.13
- DCTH 0.28
- Stochastic Oscillator
- QTRX 35.99
- DCTH 97.07
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.